|
|
| | Petesicatib Basic information |
| Product Name: | Petesicatib | | Synonyms: | Petesicatib;2-Pyrrolidinecarboxamide, N-(1-cyanocyclopropyl)-4-[[4-(1-methyl-1H-pyrazol-4-yl)-2-(trifluoromethyl)phenyl]sulfonyl]-1-[[1-(trifluoromethyl)cyclopropyl]carbonyl]-, (2S,4R)-;(2S,4R)-N-(1-Cyanocyclopropyl)-4-((4-(1-methyl-1H-pyrazol-4-yl)-2-(trifluoromethyl)phenyl)sulfonyl)-1-(1-(trifluoromethyl)cyclopropane-1-carbonyl)pyrrolidine-2-carboxamide | | CAS: | 1252637-35-6 | | MF: | C25H23F6N5O4S | | MW: | 603.54 | | EINECS: | | | Product Categories: | | | Mol File: | 1252637-35-6.mol |  |
| | Petesicatib Chemical Properties |
| Boiling point | 818.3±65.0 °C(Predicted) | | density | 1.62±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO:125.0(Max Conc. mg/mL);207.11(Max Conc. mM) | | pka | 11.51±0.20(Predicted) | | form | Solid | | color | White to off-white |
| | Petesicatib Usage And Synthesis |
| Uses | Petesicatib (RO5459072; RG-7625) is a cathepsin S inhibitor, used in research of immune diseases[1]. | | IC 50 | cathepsin S | | References | [1] Rubén Alvarez Sánchez, et al. Novel proline derivatives. US20100267722A1 |
| | Petesicatib Preparation Products And Raw materials |
|